Low-Dose Aspirin Reduces Cancer Deaths
Results of a recent study presented at the American Association for Cancer Research meeting on April 3rd suggest that long-term regular aspirin use can lower the risk of dying from several types of cancer. According to researchers, low-dose aspirin reduces the overall risk of death from cancer, as well as the risk of death from colorectal cancer, breast cancer, prostate cancer, and lung cancer.
For the study, researchers examined data from the Nurses’ Health Study conducted between 1980 and 2012 and the Health Professionals Follow-Up Study performed from 1986 to 2012. In total, the study involved more than 86,000 women and 43,000 men.
Over the course of the study, about 8,200 women and 4,600 men died of cancer. In those who took aspirin regularly, the risk of death from cancer was 7 percent lower in women and 15 percent lower in men, compared to those who did not take aspirin. Aspirin lowered the risk of death from colorectal cancer by about 30 percent in men and women. It also lowered the risk of death from breast cancer by about 11 percent and the risk of death from prostate cancer by 23 percent.
Image Credit: Thinkstock